merscov
genom
consist
nucleotid
open
read
frame
orf
singl
positivestrand
rna
genom
nucleotid
nucleotid
fig
gene
locat
play
import
role
viral
replic
wherea
gene
encod
accessori
structur
two
overlap
orf
get
translat
two
polyprotein
polyprotein
polyprotein
fig
polyprotein
cleav
function
nonstructur
protein
nsp
proteolyt
activ
two
viral
proteas
call
papainlik
proteas
plpro
proteas
selfcleavag
fig
plpro
locat
nsp
encod
orf
rnadepend
rna
polymeras
activ
exoribonucleas
activ
exoribonucleas
activ
methyl
transferas
activ
fig
play
import
role
proofread
activ
monitor
rate
gene
downstream
encod
structur
protein
spike
envelop
e
membran
nucleocapsid
n
accessori
accessori
protein
might
help
viru
immun
evas
interf
innat
immun
respons
merscov
five
accessori
protein
sarscov
eight
differ
accessori
differ
might
lead
differ
effect
induct
signal
type
interferon
ifn
could
explain
greater
sensit
ifn
merscov
viral
rna
encapsid
n
protein
transport
endoplasm
reticulumgolgi
intermedi
compart
ergic
site
assembl
viral
rna
encapsid
n
protein
bud
vesicl
line
e
dipeptidylpeptidas
identifi
hostcel
receptor
entri
merscov
sarscov
bind
larg
ectopeptidas
respect
invad
aminopeptidas
n
apn
report
entri
receptor
sever
hcov
receptor
report
far
exopeptidas
although
proteolyt
activ
necessari
viru
bind
receptor
enter
host
merscov
bind
sever
speci
bind
site
differ
differ
speci
explain
variat
suscept
merscov
infect
variou
glycoprotein
locat
surfac
merscov
virion
interact
receptor
bind
domain
enter
host
protein
consist
globular
domain
ntermin
region
domain
two
heptad
repeat
transmembran
lower
rate
mutat
report
far
merscov
transmiss
human
popul
recent
outbreak
report
shed
cell
loss
result
sever
pulmonari
report
neutrophil
chemo
repel
therefor
variat
shed
merscov
infect
could
influenc
composit
immun
infiltr
ultim
outcom
infect
also
report
express
immun
cell
includ
cell
lymphocyt
requir
optim
function
event
occur
immedi
merscov
bind
receptor
appear
similar
cov
cleavag
surfac
glycoprotein
one
necessari
step
expos
fusion
peptid
facilit
fusion
viruscel
membran
result
releas
nucleocapsid
cell
cytoplasm
sever
host
proteas
includ
cathepsin
b
member
transmembran
proteas
serin
tmprss
famili
implic
merscov
caus
acut
highli
lethal
pneumonia
renal
dysfunct
renal
dysfunct
take
place
either
due
hypox
damag
direct
infect
kidney
entri
receptor
merscov
express
high
level
neutrophil
macrophag
infiltr
alveolar
edema
report
infect
lung
tissu
mer
anim
celllin
suscept
studi
indic
merscov
may
infect
sever
human
cell
line
includ
lower
respiratori
kidney
intestin
liver
cell
well
rang
merscov
tissu
tropism
vitro
found
broader
hcov
merscov
report
elicit
attenu
innat
immun
respons
delay
proinflammatori
cytokin
induct
vitro
might
lead
immun
dysfunct
similar
find
report
among
sar
ineffect
b
cell
cell
respons
prolong
cytokin
express
also
observ
among
mer
patient
advanc
stage
diseas
clinic
symptom
includ
fever
cough
sore
throat
myalgia
chest
pain
gastrointestin
symptom
diarrhea
vomit
abdomin
respiratori
symptom
indic
lower
respiratori
tract
complic
dyspnea
cough
fever
howev
upper
respiratori
tract
complic
rare
viru
detect
upper
respiratori
tract
earli
cours
infect
lower
respiratori
tract
late
stage
case
viru
detect
urin
blood
patient
indic
possibl
system
infect
multipl
specimen
collect
differ
site
differ
time
point
increas
possibl
detect
merscov
prioriti
given
respiratori
specimen
lower
tract
obtain
case
sever
diseas
upper
tract
diseas
mild
lower
tract
specimen
obtain
potenti
risk
factor
includ
obes
diabet
mellitu
endstag
renal
diseas
cardiac
diseas
hypertens
lung
diseas
includ
asthma
cystic
fibrosi
immunosuppress
major
complic
report
fatal
case
hyperkalemia
associ
ventricular
tachycardia
dissemin
intravascular
coagul
pericard
multiorgan
coinfect
also
report
frequent
case
hematolog
manifest
includ
higher
leukocyt
count
lymphopenia
case
show
lymphocytosi
thrombocytopenia
elev
level
creatinin
lactat
dehydrogenas
alanin
aminotransferas
aspart
aminotransferas
indic
renal
liver
median
incub
period
merscov
day
slightli
longer
incub
period
sarscov
day
mer
sar
respiratori
virus
gastrointestin
manifest
report
among
patient
suffer
sarscov
merscov
infect
casefat
rate
seem
higher
merscov
around
sarscov
lesion
opac
chest
radiograph
mer
patient
report
close
resembl
pneumonia
patient
infect
lesion
mer
patient
differ
lesion
sar
patient
show
fibrocellular
intraalveolar
organ
bronchiol
obliteran
organ
pneumonia
boop
like
merscov
report
induc
greater
dysregul
host
respons
infect
sarscov
merscov
report
downregul
gene
involv
antigen
present
immun
evas
decreas
express
retino
induc
acid
gene
rig
melanoma
differenti
associ
ifn
regulatori
factor
report
bronchoalveolar
lavag
bal
serum
patient
advanc
stage
mer
howev
higher
level
cxcmotif
chemokin
ligand
cxcl
interleukin
il
report
among
patient
sever
suffer
mer
might
result
lower
express
higher
level
merscov
seem
sensit
prophylact
therapeut
vitro
immunofluoresc
assay
use
detect
merscov
igg
igm
antibodi
serum
sampl
could
determin
use
antimerscov
indirect
immunofluoresc
addit
enzymelink
immunosorb
assay
elisa
protein
microarray
technolog
microneutr
mn
assay
also
use
detect
merscov
realtim
pcr
rtpcr
assay
target
rna
upstream
e
gene
upe
also
use
accord
screen
use
rtpcr
target
upe
gene
conduct
sampl
suspect
mer
patient
posit
sampl
undergo
confirmatori
test
target
n
rtpcr
assay
report
specif
without
crossreact
respiratori
virus
includ
respiratori
sampl
collect
least
everi
day
confirm
viru
clearanc
case
two
consecut
result
western
blot
also
use
diagnosi
sampl
lower
respiratori
tract
bal
tracheal
aspir
better
suit
test
due
higher
viral
load
lower
respiratori
tract
antivir
treatment
supervis
medic
expert
recommend
mer
patient
without
comorbid
clear
symptom
efficaci
lopinavirritonavir
found
similar
experiment
trial
use
lopinavirritonavir
consid
treat
patient
use
ribavirin
possibl
due
renal
dysfunct
advers
combin
regimen
type
ifn
lopinavirritonavir
may
consid
firstlin
drug
mer
one
must
monitor
creatinin
clearanc
accord
renal
function
use
antivir
treatment
gener
recommend
day
patient
merscov
level
hemoglobin
bilirubin
haptoglobin
reticulocyt
must
monitor
care
use
ribavirin
use
lopinavirritonavir
recommend
instead
ribavirin
case
hemolyt
sinc
ribavirin
teratogen
patient
advis
plan
pregnanc
month
convalesc
plasma
therapi
shown
efficaci
among
patient
refractori
antivir
drug
administ
within
week
onset
convalesc
plasma
therapi
could
help
patient
sever
merscovspecif
peptid
fusion
inhibitor
report
novel
approach
treat
mer
need
understand
framework
establish
merscov
infect
societi
develop
control
measur
larger
outbreak
involv
pattern
recognit
receptor
downstream
signal
cellular
level
requir
understand
molecular
pathogenesi
merscov
role
accessori
protein
merscov
dissect
understand
divers
role
immun
evas
strategi
adopt
merscov
inhibit
express
need
develop
suitabl
anim
model
studi
merscov
pathogenesi
test
antivir
drug
vaccin
threat
potenti
pandem
alway
pathogen
cov
continu
spill
anim
human
popul
specif
diagnost
control
measur
requir
avoid
spread
among
healthcar
worker
nosocomi
infect
among
patient
knowledg
dynam
molecular
characterist
merscov
close
relat
cov
circul
import
understand
emerg
strengthen
diseas
surveil
diseas
prepared
